Comparison of Stroke Volume Variation-guided Normovolemic and Restrictive Fluid Management During Craniotomy: a Randomized Controlled Trial
Supratentorial Neoplasms, Brain Tumor, Primary, Craniotomy
About this trial
This is an interventional treatment trial for Supratentorial Neoplasms focused on measuring fluid therapy, neurosurgery
Eligibility Criteria
Inclusion Criteria:
- Supratentorial brain tumor receiving elective craniotomy
- BMI between 18.5-27.0 kg.m-2
Exclusion Criteria:
Cardiac dysfunction, such as coronary artery diseases; atrial fibrillation;
- NYHA class II
- Renal dysfunction, eGFR< 60 ml.min-1.1.73m-2
- Pulmonary cormorbidity, such as COPD
Sites / Locations
- National Taiwan University HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Normovolemic group (keeping SVV<10% in supine; <15% in prone)
Restricitve group (keeping SVV < 18% in supine; <23% in prone)
The anesthesiologist will infuse Voluven (Fresenius Kabi, Bad Homburg, Germany) 250 ml if stroke volume variation is over 10% during the surgery to keep the normovolemia. If total Voluven use is over 1500ml and then the anesthesiologist will infuse Saline 250 ml instead. The maintenance of basal fluid, criteria to use inotropes (If cardiac index is below 2.5 l/min/m2 ) are the same standards in the both groups.
The anesthesiologist will infuse Voluven (Fresenius Kabi, Bad Homburg, Germany) 250 ml if stroke volume variation is over 18% during the surgery to keep the normovolemia. If total Voluven use is over 1500ml and then the anesthesiologist will infuse Saline 250 ml instead. The maintenance of basal fluid, criteria to use inotropes (If cardiac index is below 2.5 l/min/m2 ) are the same standards in the both groups.